ARA-290 (cibinetide) is supplied by Onyx Peptides as a high-purity research material for laboratory use, with tracked, discreet UK dispatch.
What is ARA-290?
ARA-290 (cibinetide) is an 11-amino-acid peptide derived from part of the erythropoietin (EPO) molecule. It is designed to act on a tissue-protective receptor without EPO's effect on red blood cells.
How ARA-290 is studied
It has been studied in clinical research on nerve-related conditions and in tissue-protection models.
- Tissue-protective receptor research
- Nerve fibre models
ARA-290 from Onyx Peptides
We supply ARA-290 in 10 mg vials. Every batch is independently tested by HPLC to ≥99% purity before it is listed, and carries a batch number that links to its certificate of analysis.
Storage and delivery
Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light.
Orders are dispatched from the UK by tracked delivery in plain, discreet black padded packaging, with no product names on the outside. See shipping & delivery.
Frequently asked questions
What is ARA-290?
ARA-290 (cibinetide) is an 11-amino-acid peptide derived from part of the erythropoietin (EPO) molecule.
Is ARA-290 a licensed medicine in the UK?
ARA-290 is not a licensed medicine in the UK. Onyx Peptides supplies it only as a research material for in-vitro laboratory use.
How is ARA-290 supplied?
Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light. Each batch is HPLC-tested to at least 99% purity.
How is my order packaged?
In plain, discreet black padded packaging with no product names on the outside, sent by tracked UK delivery.
